2016-03-08T00:00:00.000-05:00
biological carcinogens,-0.50818
highly customizable nature,0.426613
lung cancer,-0.854491
Fully humanized antibodies,0.325229
cancer monoclonal antibodies,-0.348755
Conjugated cancer therapies,-0.554995
liver cancer,-0.747137
cancer cells,-0.460595
new cancer cases,-0.685622
Murine antibodies,-0.215797
adverse side-effects,-0.699593
healthy cells,-0.549485
stomach cancer,-0.785377
severe disease,-0.806608
latest industry data,0.457934
esophageal cancer,-0.850515
definite cause,-0.820419
market research solution,0.782687
Global Cancer Monoclonal,-0.374357
Long duration,-0.278593
single cell,-0.447101
monoclonal antibodies market,-0.474649
good market,0.691002
chemotherapeutic agents,-0.699593
normal cell,-0.677298
colorectal cancer,-0.782984
monoclonal antibodies,-0.0233996
good drugs,-0.57494
completely curing drugs,-0.788983
breast cancer,-0.850515
largest market,-0.323153
drug research companies,0.366447
adverse effects,-0.544508
tumor cell,-0.677298
National Cancer Institute,-0.42758
physical carcinogens,-0.314375
cancerous cells,-0.549485
chemical carcinogens,-0.420538
